Buyback Spend for Abbott Laboratories (ABT)
Buyback Spend for Abbott Laboratories (ABT): headline value $893.00M · YoY -31.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingBuyback SpendSwitch metric
Latest period
$893.00M
YoY change
-31.0%
5Y CAGR
+17.2%
Peak year (2022)
$3.79B
Latest annual
$893.00M
Buyback Spend history chart for Abbott Laboratories (ABT) from 1989 to 2025
Buyback Spend history table for Abbott Laboratories (ABT) from 1989 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $893.00M | -31.0% | ||
| 2024 | $1.29B | +5.5% | ||
| 2023 | $1.23B | -67.7% | ||
| 2022 | $3.79B | +65.1% | ||
| 2021 | $2.30B | +470.5% | ||
| 2020 | $403.00M | -43.9% | ||
| 2019 | $718.00M | +201.7% | ||
| 2018 | $238.00M | -71.2% | ||
| 2017 | $827.00M | +58.4% | ||
| 2016 | $522.00M | -76.7% | ||
| 2015 | $2.24B | +1.9% | ||
| 2014 | $2.19B | +36.8% | ||
| 2013 | $1.60B | -32.1% | ||
| 2012 | $2.36B | +2969.9% | ||
| 2011 | $77.01M | -91.1% | ||
| 2010 | $866.83M | +4.9% | ||
| 2009 | $826.35M | -23.6% | ||
| 2008 | $1.08B | +2.2% | ||
| 2007 | $1.06B | +40.3% | ||
| 2006 | $754.50M | -42.1% | ||
| 2005 | $1.30B | +160.6% | ||
| 2004 | $499.75M | +411.9% | ||
| 2003 | $97.62M | — | ||
| 2002 | $0 | -100.0% | ||
| 2001 | $17.36M | -96.3% | ||
| 2000 | $464.86M | — | ||
| 1999 | $0 | -100.0% | ||
| 1998 | $876.30M | -16.9% | ||
| 1997 | $1.05B | +30.4% | ||
| 1996 | $808.80M | +4.8% | ||
| 1995 | $771.41M | +25.2% | ||
| 1994 | $615.95M | +32.2% | ||
| 1993 | $465.82M | -23.3% | ||
| 1992 | $607.60M | +91.2% | ||
| 1991 | $317.80M | -47.5% | ||
| 1990 | $605.60M | +109.2% | ||
| 1989 | $289.50M | — |
Buyback Spend values are taken from Abbott Laboratories's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Abbott Laboratories (ABT) most recent annual buyback spend stands at $893.00M (2025) – plunged 31.0% year-over-year.
Across 2020–2025 (5 years), Abbott Laboratories buyback spend produced a CAGR of +17.2% – with the latest reading among the more recent periods of the dataset.
Between 2022 and 2025, Abbott Laboratories buyback spend plunged 76.5%, falling from $3.79B to $893.00M.
The dataset's maximum buyback spend sits at $3.79B (2022); the minimum reading of $0 dates to 1999.
Within Healthcare, Abbott Laboratories (ABT) ranks 7th among 8 peers we track. The peer median for buyback spend is $2.75B.
Abbott Laboratories Buyback Spend by Year
Abbott Laboratories Buyback Spend 2025: $893.00M
Abbott Laboratories buyback spend in 2025 was $893.00M, plunged 31.0% below 2024.
Abbott Laboratories Buyback Spend 2024: $1.29B
Abbott Laboratories buyback spend in 2024 was $1.29B, grew 5.5% from 2023.
Abbott Laboratories Buyback Spend 2023: $1.23B
Abbott Laboratories buyback spend in 2023 was $1.23B, plunged 67.7% below 2022.
Abbott Laboratories Buyback Spend 2022: $3.79B
Abbott Laboratories buyback spend in 2022 was $3.79B, surged 65.1% from 2021. This figure represents the highest annual value in the available history.
Abbott Laboratories Buyback Spend 2021: $2.30B
Abbott Laboratories buyback spend in 2021 was $2.30B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Buyback Spend
Companies in the same sector as Abbott Laboratories, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Abbott Laboratories's buyback spend?
Latest reported buyback spend for Abbott Laboratories (ABT) is $893.00M (period ending December 31, 2025).
How has Abbott Laboratories buyback spend changed year-over-year?
Abbott Laboratories (ABT) buyback spend changed -31.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories buyback spend?
Abbott Laboratories (ABT) buyback spend compound annual growth rate is +17.2% over the most recent 5 years available.
When did Abbott Laboratories buyback spend hit its highest annual value?
Abbott Laboratories buyback spend reached its highest annual value of $3.79B in 2022.
What was Abbott Laboratories buyback spend in 2024?
Abbott Laboratories (ABT) buyback spend in 2024 was $1.29B.
What was Abbott Laboratories buyback spend in 2025?
Abbott Laboratories (ABT) buyback spend in 2025 was $893.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.